Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | EXTR | Common Stock | Options Exercise | $161K | +64.2K | +8.58% | $2.51* | 812K | Dec 7, 2021 | Direct | |
transaction | EXTR | Common Stock | Sale | -$901K | -64.2K | -7.9% | $14.04 | 748K | Dec 7, 2021 | Direct | F1, F2 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | EXTR | Non-Qualified Stock Option (right to buy) | Options Exercise | $0 | -64.2K | -24.3% | $0.00 | 200K | Dec 7, 2021 | Common Stock | 64.2K | $2.51 | Direct | F3 |
Id | Content |
---|---|
F1 | Transaction pursuant to the Reporting Person's 10b5-1 Plan. |
F2 | The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.00 to $14.15 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
F3 | This Performance Option Grant vested monthly over 2 years from the date of Grant and was achieved after the Company's Common Stock closing price exceeded $5.50 for 30 consecutive trading days on March 16, 2017. |